Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03872505
Title Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer (PANDoRA)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Cedars-Sinai Medical Center
Indications

triple-receptor negative breast cancer

Therapies

Carboplatin + Durvalumab + Paclitaxel

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.